Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Because it is classed as a cosmetic rather than a medical treatment, it has not been through the same safety and efficacy testing as regulated fat reduction options
Separate research comparing tirzepatide to dulaglutide in patients with high-risk chronic kidney disease and type 2 diabetes found that tirzepatide may reduce risks for kidney function decline, albuminuria increases, and composite major kidney events
Convenient and Non-Invasive The nasal spray delivery method provides a painless and easy alternative to injections, making it ideal for regular use
Tirzepatide carries a boxed warning regarding thyroid cancer risk and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
"It's going to make a big play in reducing the incidences of obesity and therefore diabetes and therefore the long-term complications associated with this condition." Despite this, there's still questions around whether generics will stack up to Novo Nordisk's brand name version
US$ 24.05
US$ 28.85
US$ 28.93
